Ochre News
NEWS COVERAGE
RNA therapies startup Ochre Bio lands $30M to take on chronic liver disease
- October 10, 2022
A liver disease upstart with some global connections and a new R&D strategy reaps a $30M launch round
- October 10, 2022
Chirps, chats and Clubhouses: First-time biotech founders turn to social media for advice, investors and recruitment
- April 4, 2022
Lyfebulb and CSL Behring Announce the Finalists for the 2021 Transplant Innovation Challenge
- March 5, 2022
‘Day job and a gay job’: LGBTQ+ leaders in biopharma want those who look, talk and love like them to be seen and counted
- December 8, 2021
Biotech looks to upset the preclinical model for liver drug development, and now it’s gearing up for the clinic
- June 16, 2021
